AVA Stockpile Analysis-Supplemental Testing Needed and/or Resolvable FDA Issues

November 13, 1998

LOT

Inventory

Cumulative Inventory

Expiration Date

FDA HOLD

SUPP TESTING

FAVO09

63840

63840

30-Aug-97

NONE

POTENCY

FAV010

204870

268710

11-Oct-97

NONE

POTENCY

FAV013

206610

475320

22-Nov-97

NONE

POTENCY, PHEMEROL

FAY014

214100

689420

25-Jul-98

NONE

PHEMEROL

FAV015

210050

899470

29-Sep-98

NONE

PHEMEROL

FAV015

135730

1035200

11-Jun-99

PARTICULATES

PHEMEROL

FAV018

189810

1225010

11-Jun-99

POTENCY

POTENCY

FAV021

214600

1439510

28-Jan-00

POTENCY

NONE

FAV022

193970

1633580

15-Oct-99

POTENCY

POTENCY

FAV023

203030

1836610

29-Mar-97

POTENCY

POTENCY

FAV024

208880

2045490

11-Apr-00

NONE

POTENCY

FAV025

214810

2260300

24-May-97

POTENCY

POTENCY

FAV028

177720

2438020

27-Aug-99

POTENCY

POTENCY

FAV029

197790

2635810

9-Jul-99

STERILITY ASSURANCE

POTENCY

FAV031

189700

2825510

6-0ct-97

NONE

NONE

FAV032

201090

3026600

6-Oct-98

STERILITY ASSURANCE

POTENCY

FAV035

202500

3229100

28-Jan-00

STERILITY ASSURANCE

POTENCY

FAV037

207650

3436750

25-Feb-00

NONE

POTENCY

FAV039

189190

3625940

25-Feb-00

NONE

POTENCY

Note 1) For expired lots, FDA must accept a longer dating period or extension of dating; needs regulatory submission.

Note 2) Entries of "POTENCY'' require mom testing and/or approval of pending supplement for method of calculation of potency.

Note 3) Entries of "Phemerol" require an FDA approval of a yet to be submitted request for a change in the Phemerol specification.

Note 4) Anticipate approvals by May, 1999, but there are no guarantees that FDA will approve.